Why BioCryst Pharmaceuticals Stock Jumped Today
Shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) up 10.8% to around $4.76 Friday as of 3:30 p.m. EDT. The big gain came after JMP Securities analyst Jonathan Wolleben bumped his price target for the stock up to $11 from $10.
It's typically best to take analysts' price targets for stocks with a grain of salt. However, understanding the rationales behind their perspectives can be helpful in evaluating the prospects for a company.
Image source: Getty Images.
Source Fool.com
